News Letter to Shareholders and Corporate Update Continue Reading Previous Sandoz announces exclusive deal to commercialize biosimilar ustekinumab, further reinforcing growing pipeline and immunology patient offeringNext Verona Pharma Announces the US FDA has Accepted the New Drug Application Filing for Ensifentrine for the Maintenance Treatment of COPD Related Stories News Descartes’ Study Finds 67% of Freight Forwarders and Customs Brokers View Technology as Fundamental to Growth News Intuitive doubles down on AI with the launch of Intuitive.ai powered by aiE™ framework to build the future of intelligent enterprises News Dash Social Unveils the Total Social Impact Score: The New Standard for Brands to Measure Their Social Footprint News Franklin Wireless Begins Shipping its first 5G Fixed Wireless Router Built for Resilient Connectivity Across Communities and Networks News From Hong Kong Airport to Hengqin: Chimelong Ferry Sets Sail for a Worry-Free Journey News BlackBerry and Universiti Kebangsaan Malaysia Announce Strategic Partnership to Advance Malaysia’s Future Cyber-Defenders and Embedded Software Talent
